Yahoo Finance Results
- Thomson Reuters StreetEvents via Yahoo FinanceApr 12 12:45 PM
And that's the reason we go to work every day and everyone -- and really is something that's important to us. How do we do that? One is by delivering an innovative pipeline, hopefully with drugs that actually make a difference in patients' lives.
- Market Watch18 hours ago
- Market Watch4 days ago
- CNBC6 days ago
- Motley Fool via Yahoo FinanceApr 21 11:21 AM
The risks associated with trial failures, competitive threats, and patent expirations make biotech stocks some of the riskiest stocks investors can buy, but that doesn't mean that you should ...
- Zacks via Yahoo FinanceApr 20 16:34 PM
Shire plc SHPG announced that it has rejected the Japanese company Takeda Pharmaceutical’s third offer to acquire it in a cash-stock deal for 46.50 pounds per share or around $63 billion. The ...
- Motley Fool via Yahoo FinanceApr 20 20:16 PM
Dicerna Pharmaceuticals (NASDAQ: DRNA) is up 18.6% at 3:31 p.m. EDT after announcing that it settled a trade secrets lawsuit with Alnylam Pharmaceuticals (NASDAQ: ALNY), which is up 1.3% itself ...
Critical Mass: In First Post 'Cyan' Decision, Court Splits Blockchain Lawsuit Into Two. Plus, Facebook Class Actions to Headline...ALM Media via Yahoo FinanceApr 24 6:00 AM
First Post-'Cyan' Decision Splits Blockchain Case in Two The U.S. Supreme Court’s decision last month in Cyan v. Beaver County Employees Retirement Fund is already having an impact in trial ...
News about Sanofi-Aventis. Commentary and archival information about Sanofi-Aventis from The New York Times.
Stock analysis for Sanofi (SAN:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Sanofi S.A. stock price, stock quotes and financial overviews from MarketWatch.
FR:SAN - Sanofi S.A. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.
- related to Sanofi S.A